C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
NCT01530269
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Prostate Adenocarcinoma
Interventions
DRUG:
C11-Sodium Acetate
Sponsor
Phoenix Molecular Imaging